drugset / Trial / NCT01831479

Investigation of Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan in Healthy Male Volunteers

NCT01831479

Phase 1 Completed 36 enrolled Severance Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study investigates pharmacokinetics and drug-drug interaction between Rosuvastatin and Olmesartan in healthy male volunteers

Timeline

Start
2011-08
Primary completion
2011-09
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Olmesartan Other / unclassified 40 mg Oral
Subject Rosuvastatin Small molecule 20 mg Oral

Indications

No indication recorded.